Project

Medicine Safety Improvement Programme

Focus areas:
Locality:
Wessex
Compilation of images of people working in health and social care

The National Medicines Safety Improvement Programme (MedSIP) is part of The NHS Patient Safety Strategy The programme aims to address the most important causes of severe harm associated with medicines, that continue to challenge the health and care systems in England.

A new programme launched in April 2025 is focused on reducing harm from psychotropics used for behaviour that challenges in people with a learning disability. Behaviour that challenges is not a diagnosis, it describes a range of behaviours that some people with learning disability may display when their needs are not being met.


Compilation of images of people working in health and social care

There are about 1.3 million people with a learning disability in England. Approximately 14% of people with a learning disability are prescribed antipsychotic medicines compared to 1% of people without a learning disability. Where possible, psychotropic medicines should be avoided for behaviour that challenges. But when needed, prescribing should be at the lowest dose, be reviewed regularly, and stopped as soon as possible.  

Psychotropic medications include antipsychotics, antidepressants, anxiolytics (benzodiazepines), anti-seizure medication (antiepileptics), sedatives (including hypnotics) and stimulants. They affect the working of the brain and impact on a person’s mood, thoughts, perceptions and behaviour. These medications can often have side-effects and can also affect a person’s quality of life, so should only be used if there is a clear clinical indication.  

We are supporting our integrated care systems to take a systems approach to change that brings together NHS providers, social care, voluntary sector and lived experience.


Meet our Innovation adoption team

How can we help you?

If you’d like to get in touch please
email medicines.optimisation@hiwessex.net

More projects

See all projects

Case studies

See all case studies

Events

See all events

News

See all news

Videos & podcasts

See all videos & podcasts

Stay connected, sign up for
our monthly newsletter

Sign up now Funding newsletter